Clarivate Plc [NYSE: CLVT] gained 1.77% on the last trading session, reaching $24.17 price per share at the time. The company report on September 13, 2021 that Clarivate Announces Winner of Eugene Garfield Award 2021.
Elena Pallari receives $25,000 for proposal for innovation in clinical research assessment.
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, named Elena Pallari, Department of Clinical Trials and Methodology, University College London, U.K., as the recipient of the 2021 Eugene Garfield Award for Innovation in Citation Analysis. The award was announced at the 25th International Conference on Science, Technology and Innovation Indicators (STI 2021) by Dr. Gali Halevi, Director of the Institute for Scientific Information (ISI)™ at Clarivate.
Clarivate Plc represents 617.42 million in outstanding shares, while the company has a total market value of $17.22 billion with the latest information. CLVT stock price has been found in the range of $23.795 to $24.46.
If compared to the average trading volume of 4.62M shares, CLVT reached a trading volume of 5636836 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Clarivate Plc [CLVT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLVT shares is $31.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLVT stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for Clarivate Plc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 16, 2021. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Outperform. The new note on the price target was released on August 04, 2021, representing the official price target for Clarivate Plc stock. Previously, the target price had yet another raise to $30, while Jefferies analysts kept a Buy rating on CLVT stock.
The Average True Range (ATR) for Clarivate Plc is set at 0.76, with the Price to Sales ratio for CLVT stock in the period of the last 12 months amounting to 10.67. The Price to Book ratio for the last quarter was 1.48, with the Price to Cash per share for the same quarter was set at 3.59. Price to Free Cash Flow for CLVT in the course of the last twelve months was 57.31 with Quick ratio for the last quarter at 1.60.
Trading performance analysis for CLVT stock
Clarivate Plc [CLVT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.96. With this latest performance, CLVT shares gained by 3.82% in over the last four-week period, additionally sinking by -7.00% over the last 6 months – not to mention a drop of -12.59% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLVT stock in for the last two-week period is set at 44.37, with the RSI for the last a single of trading hit 39.65, and the three-weeks RSI is set at 45.89 for Clarivate Plc [CLVT]. The present Moving Average for the last 50 days of trading for this stock 24.57, while it was recorded at 25.42 for the last single week of trading, and 26.91 for the last 200 days.
Clarivate Plc [CLVT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Clarivate Plc [CLVT] shares currently have an operating margin of -0.16 and a Gross Margin at +41.59. Clarivate Plc’s Net Margin is presently recorded at -24.87.
Return on Total Capital for CLVT is now -0.02, given the latest momentum, and Return on Invested Capital for the company is -3.92. Return on Equity for this stock declined to -5.86, with Return on Assets sitting at -3.28. When it comes to the capital structure of this company, Clarivate Plc [CLVT] has a Total Debt to Total Equity ratio set at 39.07. Additionally, CLVT Total Debt to Total Capital is recorded at 28.10, with Total Debt to Total Assets ending up at 23.86. Long-Term Debt to Equity for the company is recorded at 38.38, with the Long-Term Debt to Total Capital now at 27.60.
Reflecting on the efficiency of the workforce at the company, Clarivate Plc [CLVT] managed to generate an average of -$35,888 per employee. Receivables Turnover for the company is 2.34 with a Total Asset Turnover recorded at a value of 0.13.Clarivate Plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.60 and a Current Ratio set at 1.60.
Clarivate Plc [CLVT]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLVT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clarivate Plc go to 19.80%.
An analysis of insider ownership at Clarivate Plc [CLVT]
There are presently around $11,246 million, or 85.40% of CLVT stock, in the hands of institutional investors. The top three institutional holders of CLVT stocks are: LEONARD GREEN & PARTNERS, L.P. with ownership of 116,666,507, which is approximately 0% of the company’s market cap and around 0.70% of the total institutional ownership; PRICE T ROWE ASSOCIATES INC /MD/, holding 69,250,541 shares of the stock with an approximate value of $1.67 billion in CLVT stocks shares; and SELECT EQUITY GROUP, L.P., currently with $1.21 billion in CLVT stock with ownership of nearly 4.848% of the company’s market capitalization.
Positions in Clarivate Plc stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 233 institutional holders increased their position in Clarivate Plc [NYSE:CLVT] by around 88,535,103 shares. Additionally, 54 investors decreased positions by around 19,990,564 shares, while 20 investors held positions by with 356,755,410 shares. The mentioned changes placed institutional holdings at 465,281,077 shares, according to the latest SEC report filing. CLVT stock had 121 new institutional investments in for a total of 39,310,027 shares, while 20 institutional investors sold positions of 1,922,593 shares during the same period.